JARRET HELSTERN: Open Payments
NPI 1992169015 · SKOKIE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$11,255 in 224 payments from 26 companies in 2025. Trend: 2023 $33,679 · 2024 $51,791 · 2025 $11,255
Speaker / faculty: $6,794Food & beverage: $4,248Consulting: $115Travel & lodging: $90Education: $8
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 15 | $4,520 |
| ABBVIE INC. | 52 | $3,281 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 21 | $540 |
| Alkermes, Inc. | 12 | $362 |
| Lundbeck LLC | 21 | $359 |
| Neurocrine BioSciences, Inc. | 12 | $279 |
| Neos Therapeutics, LP | 8 | $234 |
| Supernus Pharmaceuticals, Inc. | 18 | $213 |
| Teva Pharmaceuticals USA, Inc. | 4 | $192 |
| Bausch Health US, LLC | 11 | $184 |
Products named: REXULTI, VRAYLAR, CAPLYTA, INGREZZA, SPRAVATO, Adzenys XR-ODT, Qelbree, LYBALVI.
Industry payments across IL — which companies pay providers there.
